Pluristem Receives Response from U.S. BARDA for Acute Radiation Syndrome Research Proposal

NEXT STORY
Kura Oncology Receives Fast Track Designation for Tipifarnib in T-Cell Lymphomas
PREV STORY
Global Proteomics Market Outlook, 2026 – $27+ Billion Opportunity Assessment with Profiles of Key Industry Players
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia —Successfully Completes Second of Four Dosing Cohorts

MORRISTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that patient ...

author_avatar
NASDAQ Market News

Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation

 ORION CORPORATION                                            PRESS RELEASE                      10 SEPTEMBER 2018 Johanna Ivaska has been appointed Head & ...

author_avatar
NASDAQ Market News

Castle Rock Veterinarian Brekke Veterinary Clinic Reminds Pet Owners About Heartworm Risk During Heartworm Awareness Month

CASTLE ROCK, Colo., April 23, 2017 (GLOBE NEWSWIRE) -- April is Heartworm Awareness Month ...

author_avatar
NASDAQ Market News